Found 10 matching trials
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 This phase I trial is studying the side effects of decitabine when given to...
Show More Location
Nevada Cancer Institute-Summerlin Campus
Learn More & Join Trial
Pilot Study of IFN α2b for Melanoma Patients EARLY_PHASE1 The presence of malignant cells in lymph nodes is a critical parameter in t...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C PHASE1 The purpose of this study is to assess the safety, pharmacokinetics, HCV RN...
Show More Location
Toranomon Hospital
Learn More & Join Trial
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy PHASE3 HRN-003 STUDY SYNOPSIS
OBJECTIVE: To compare the Sustained Virologic Respo...
Show More Location
Johns Hopkins Univesity School of Medicine
Learn More & Join Trial
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV PHASE2 We propose to test our primary hypothesis that treatment with Peg-IFN-α-2b ...
Show More Location
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine
Learn More & Join Trial
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma PHASE3 This randomized phase III trial is studying combination chemotherapy follow...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon PHASE3 Objectives:
Primary To compare the sustained virologic response (SVR) of P...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 PHASE2 Three-parallel-arm, open-label, international (France and Romania) study, c...
Show More Location
Hôpital de la Croix Rousse
Learn More & Join Trial
Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia PHASE2 To investigate whether patients with chronic-phase chronic myeloid leukemia...
Show More Location
Universtiy of Michigan
Learn More & Join Trial
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors PHASE2 This randomized phase II trial is to see if combining bevacizumab with PEG-...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial